{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:52:13Z","timestamp":1773168733045,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T00:00:00Z","timestamp":1466640000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10157-016-1297-1","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T18:30:09Z","timestamp":1466706609000},"page":"375-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polyuria due to vasopressin V2 receptor antagonism is not associated with increased ureter diameter in ADPKD patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Niek F.","family":"Casteleijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Lianne","family":"Messchendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyong T.","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Higashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kappert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Leliveld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,23]]},"reference":[{"key":"1297_CR1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","volume":"28","author":"HP Neumann","year":"2013","unstructured":"Neumann HP, Jilg C, Bacher J, et al. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transplant. 2013;28:1472\u201387.","journal-title":"Nephrol Dial Transplant"},{"key":"1297_CR2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000045214","volume":"80","author":"E Higashihara","year":"1998","unstructured":"Higashihara E, Nutahara K, Kojima M, et al. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron. 1998;80:421\u20137.","journal-title":"Nephron"},{"key":"1297_CR3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008;359:1477\u201385.","journal-title":"N Engl J Med"},{"key":"1297_CR4","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367:2407\u201318.","journal-title":"N Engl J Med"},{"issue":"9","key":"1297_CR5","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.V1091958","volume":"10","author":"AF Lieburg van","year":"1999","unstructured":"van Lieburg AF, Knoers NV, Monnens LA. Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol. 1999;10(9):1958\u201364.","journal-title":"J Am Soc Nephrol"},{"key":"1297_CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11255-006-0093-3","volume":"38","author":"M Hora","year":"2006","unstructured":"Hora M, Reischig T, Hes O, et al. Urological complications of congenital nephrogenic diabetes insipidus\u2014long-term follow-up of one patient. Int Urol Nephrol. 2006;38:531\u20132.","journal-title":"Int Urol Nephrol"},{"key":"1297_CR7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1442-200X.2002.01599.x","volume":"44","author":"A Higuchi","year":"2002","unstructured":"Higuchi A, Kawamura T, Nakai H, et al. Infrequent voiding in nephrogenic diabetes insipidus as a cause of renal failure. Pediatr Int. 2002;44:540\u20132.","journal-title":"Pediatr Int"},{"key":"1297_CR8","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1093\/ndt\/gfh229","volume":"19","author":"A Korzets","year":"2004","unstructured":"Korzets A, Sachs D, Gremitsky A, et al. Unexplained polyuria and non-obstructive hydronephrosis in a urological department. Nephrol Dial Transplant. 2004;19:2410\u20132.","journal-title":"Nephrol Dial Transplant"},{"key":"1297_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2214\/ajr.133.2.327","volume":"133","author":"RB Harrison","year":"1979","unstructured":"Harrison RB, Ramchandani P, Allen JT. Psychogenic polydipsia: unusual cause for hydronephrosis. AJR Am J Roentgenol. 1979;133:327\u20138.","journal-title":"AJR Am J Roentgenol"},{"key":"1297_CR10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/1752-1947-6-376","volume":"6","author":"N Maroz","year":"2012","unstructured":"Maroz N, Maroz U, Iqbal S, et al. Nonobstructive hydronephrosis due to social polydipsia: a case report. J Med Case Rep. 2012;6:376\u20138.","journal-title":"J Med Case Rep"},{"key":"1297_CR11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0272-6386(95)90593-6","volume":"26","author":"H Singh","year":"1995","unstructured":"Singh H, Linas SL. Compulsive water drinking in the setting of anticholinergic drug use: an unrecognized cause of chronic renal failure. Am J Kidney Dis. 1995;26:586\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1297_CR12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.ajkd.2010.11.029","volume":"57","author":"VE Torres","year":"2011","unstructured":"Torres VE, Meijer E, Bae KT, et al. Rationale and design of the TEMPO (tolvaptan efficacy and safety in management of autosomal dominant polycystic kidney disease and its outcomes) 3\u20134 Study. Am J Kidney Dis. 2011;57:692\u20139.","journal-title":"Am J Kidney Dis"},{"key":"1297_CR13","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ki.2013.285","volume":"84","author":"WE Boertien","year":"2013","unstructured":"Boertien WE, Meijer E, de Jong PE, et al. Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. Kidney Int. 2013;84:1278\u201386.","journal-title":"Kidney Int"},{"key":"1297_CR14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"1297_CR15","first-page":"97","volume":"20","author":"AJ Donker","year":"1977","unstructured":"Donker AJ, van der Hem GK, Sluiter WJ, et al. A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med. 1977;20:97\u2013103.","journal-title":"Neth J Med"},{"key":"1297_CR16","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1681\/ASN.V74567","volume":"7","author":"AJ Apperloo","year":"1996","unstructured":"Apperloo AJ, de Zeeuw D, Donker AJ, et al. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol. 1996;7:567\u201372.","journal-title":"J Am Soc Nephrol"},{"key":"1297_CR17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00004728-200007000-00019","volume":"24","author":"KT Bae","year":"2000","unstructured":"Bae KT, Commean PK, Lee J. Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr. 2000;24:614\u20139.","journal-title":"J Comput Assist Tomogr"},{"key":"1297_CR18","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00261-013-0019-3","volume":"38","author":"G Masselli","year":"2013","unstructured":"Masselli G, Derme M, Laghi F, et al. Imaging of stone disease in pregnancy. Abdom Imaging. 2013;38:1409\u201314.","journal-title":"Abdom Imaging"},{"key":"1297_CR19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1148\/radiology.203.2.9114093","volume":"203","author":"V Blomlie","year":"1997","unstructured":"Blomlie V, Rofstad EK, Trope C, Lien HH. Critical soft tissues of the female pelvis: serial MR imaging before, during, and after radiation therapy. Radiology. 1997;203:391\u20137.","journal-title":"Radiology"},{"key":"1297_CR20","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1007\/s003300000536","volume":"10","author":"GA Verswijvel","year":"2000","unstructured":"Verswijvel GA, Oyen RH, Van Poppel HP, et al. Magnetic resonance imaging in the assessment of urologic disease: an all-in-one approach. Eur Radiol. 2000;10:1614\u20139.","journal-title":"Eur Radiol"},{"key":"1297_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.rcl.2012.02.008","volume":"50","author":"P Bhargava","year":"2012","unstructured":"Bhargava P, Dighe MK, Lee JH, Wang C. Multimodality imaging of ureteric disease. Radiol Clin N Am. 2012;50:271\u201399.","journal-title":"Radiol Clin N Am"},{"key":"1297_CR22","first-page":"462","volume":"63","author":"FI Spiro","year":"1970","unstructured":"Spiro FI, Fry IK. Ureteric dilatation in nonpregnant women. Proc R Soc Med. 1970;63:462\u20136.","journal-title":"Proc R Soc Med"},{"key":"1297_CR23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2214\/ajr.182.4.1821039","volume":"182","author":"N Zelenko","year":"2004","unstructured":"Zelenko N, Coll D, Rosenfeld AT, et al. Normal ureter size on unenhanced helical CT. AJR Am J Roentgenol. 2004;182:1039\u201341.","journal-title":"AJR Am J Roentgenol"},{"key":"1297_CR24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1176\/ajp.140.7.915","volume":"140","author":"A Blum","year":"1983","unstructured":"Blum A, Friedland GW. Urinary tract abnormalities due to chronic psychogenic polydipsia. Am J Psychiatry. 1983;140:915\u20136.","journal-title":"Am J Psychiatry"},{"key":"1297_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ctr.12514","volume":"29","author":"M Weber","year":"2015","unstructured":"Weber M, Berglund D, Reule S, et al. Daily fluid intake and outcomes in kidney recipients: post hoc analysis from the randomized ABCAN trial. Clin Transplant. 2015;29:261\u20137.","journal-title":"Clin Transplant"},{"key":"1297_CR26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1025910025216","volume":"35","author":"DH Zermann","year":"2003","unstructured":"Zermann DH, Loffler U, Reichelt O, et al. Bladder dysfunction and end stage renal disease. Int Urol Nephrol. 2003;35:93\u20137.","journal-title":"Int Urol Nephrol"},{"key":"1297_CR27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2215\/CJN.00790209","volume":"4","author":"VE Torres","year":"2009","unstructured":"Torres VE, Bankir L, Grantham JJ. A case for water in the treatment of polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4:1140\u201350.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1297_CR28","unstructured":"European Medicines Agency. Summary of medicinal product characteristics Jinarc. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002788\/WC500187921.pdf . Accessed 10 Nov 2015."},{"key":"1297_CR29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/00365590802580208","volume":"43","author":"XD Jin","year":"2009","unstructured":"Jin XD, Chen ZD, Cai SL, et al. Nephrogenic diabetes insipidus with dilatation of bilateral renal pelvis, ureter and bladder. Scand J Urol Nephrol. 2009;43:73\u20135.","journal-title":"Scand J Urol Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1297-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1297-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1297-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T03:02:57Z","timestamp":1656730977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1297-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,23]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1297"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1297-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,23]]}}}